American Spatial Biology Congress

Learn more

May 9 - 10

San Diego US

Visit our booth #3

Conference Information

Join us in San Diego for the American Spatial Biology Congress. 

Meet our scientists on-site and discover our universal, end-to-end spatial biology solution, answering fundamental research needs involving biomarker screening and tissue profiling.  

Our solutions allow you to leverage your existing antibody library and get reproducible results while providing hyperplex capabilities for biomarker discovery. 

Want to know more about our spatial biology solutions? Send us a message and secure a meeting with the team. 

In this rapidly developing field, spatial biology provides significant potential for creating novel clinical insights. Recent technological advancements in spatial biology have provided insights into new strategies to prevent and treat disease, particularly the interactions between the tumour and the tumour microenvironment in cancers to target patients to more specific treatments. New spatial research has focused more on the analysis of the transcriptome, epigenome, and metabolomics as well as gene and protein expression to discover how these influence cellular and molecular distributions and interactions.

With a single track over two days, featuring more than 30 presentations, you will discover the latest developments in spatial omics and techniques, bioinformatics, and spatial biology data analysis, as well as the application of spatial biology to disease and drug development. There will also be a dynamic exhibition room filled with providers showcasing their spatial technologies with ample networking opportunities, an interactive panel discussion, roundtables, and a poster competition.

May 9


May 9

14:20 - 14:35

Track 1

  • Spatial profiling of both RNA and protein markers on the same tissue at the single-cell level is required for the discovery and validation of spatial biomarkers. 
  • Here, we show a novel multiomics approach that integrates RNAscope™ and sequential immunofluorescence (seqIF™) to simultaneously identify RNA and protein targets on the same tissue section in a fully automated workflow. 
  • This unique approach will enable researchers to generate highly reproducible data to characterize novel molecular signatures and support the development of targeted therapies. 


Andreas Wiesner, Ph.D.

Andreas Wiesner, Ph.D.

Head of Product Management

Lunaphore Technologies, a Bio-Techne brand

Dr. Andreas Wiesner is Head of Product Management for Lunaphore Technologies, a Bio-Techne brand. He obtained his Ph.D. in Neurobiology at the ETH Zürich, Switzerland and conducted research in proteomics of Alzheimer’s Disease at the Brain and Mind Research Institute of the University of New South Wales in Sydney, Australia. During his 15 years in Product Management, he covered various industries, including research, biopharma, and CAR-T cell manufacturing, and led the commercialization of many products in cell culture, microfluidics, and proteomics. He joined Lunaphore Technologies in 2021 and, together with his team, has built Lunaphore’s product portfolio consisting of the hyperplex, immunofluorescence platform COMET™ for automated staining and imaging, SPYRE™ antibodies and Panel Builder for modular and instant mIF protocols, and HORIZON™, the specialized mIF tissue analysis software making Spatial Biology analysis intuitive even for beginners.